Table 1 Numbers of cases and age-standardized rates (per million population) with 95% confidence intervals (CIs) by diagnosis, age-group and sex, 1968–2005
Ages 0–14 | Ages 15–24 | ||||
|---|---|---|---|---|---|
No. | Rate (95% CI) | No. | Rate (95% CI) | ||
CNS tumours | M | 382 | 31.7 (28.5,35.0) | 224 | 27.3 (23.7,30.9) |
F | 309 | 27.6 (24.4,30.7) | 165 | 20.2 (17.1,23.3) | |
Ependymomas | M | 51 | 4.6 (3.3,5.8) | 21 | 2.6 (1.6,3.9) |
F | 21 | 2.0 (1.2,3.1) | 6 | 0.8 (0.3,1.6) | |
Astrocytomas | M | 137 | 11.1 (9.2,12.9) | 76 | 9.3 (7.2,11.4) |
F | 126 | 11.2 (9.2,13.1) | 54 | 6.6 (4.8,8.4) | |
PNET | M | 78 | 6.7 (5.2,8.2) | 13 | 1.6 (0.8,2.7) |
F | 45 | 4.2 (3.0,5.4) | 7 | 0.9 (0.4,1.8) | |
Other gliomas | M | 34 | 2.9 (1.9,3.8) | 36 | 4.3 (2.9,5.8) |
F | 34 | 3.0 (2.0,4.0) | 26 | 3.2 (2.1,4.7) | |
Sympathetic nervous system tumours | M | 102 | 9.8 (7.9,11.7) | 9 | 1.1 (0.5,2.1) |
F | 95 | 9.7 (7.8,11.7) | 9 | 1.1 (0.5,2.2) | |
Retinoblastoma | M | 38 | 3.9 (2.6,5.1) | 0 | - |
F | 50 | 5.4 (3.9,6.8) | 0 | - | |
Renal tumours | M | 71 | 6.8 (5.2,8.4) | 8 | 0.9 (0.4,1.8) |
F | 85 | 8.7 (6.9,10.6) | 7 | 0.8 (0.3,1.7) | |
Hepatoblastomas | M | 7 | 0.7 (0.3,1.5) | 0 | - |
F | 10 | 1.0 (0.5,1.9) | 2 | 0.2 (0.0,0.8) | |
Bone tumours | M | 65 | 4.7 (3.5,5.8) | 114 | 14.2 (11.6,16.8) |
F | 56 | 4.3 (3.2,5.5) | 66 | 8.3 (6.3,10.3) | |
Osteosarcoma | M | 34 | 2.4 (1.6,3.3) | 60 | 7.5 (5.6,9.5) |
F | 37 | 2.8 (1.9,3.8) | 39 | 4.9 (3.4,6.5) | |
Ewing's sarcoma | M | 29 | 2.1 (1.4,3.0) | 36 | 4.5 (3.0,5.9) |
F | 16 | 1.3 (0.7,2.1) | 16 | 2.0 (1.2,3.3) | |
Soft tissue sarcomas | M | 127 | 11.0 (9.1,13.0) | 89 | 10.9 (8.6,13.2) |
F | 72 | 6.2 (4.8,7.7) | 94 | 11.7 (9.3,14.0) | |
Rhabdomyosarcoma | M | 75 | 6.8 (5.3,8.4) | 14 | 1.8 (1.0,3.0) |
F | 39 | 3.6 (2.5,4.7) | 21 | 2.7 (1.6,4.1) | |
Other | M | 52 | 4.2 (3.0,5.4) | 75 | 9.1 (7.1,11.2) |
F | 33 | 2.6 (1.7,3.5) | 73 | 9.0 (6.9,11.1) | |
Germ cell tumours | M | 55 | 5.2 (3.8,6.6) | 292 | 34.8 (30.8,38.8) |
F | 60 | 5.5 (4.1,6.9) | 127 | 15.4 (12.7,18.1) | |
Gonadal | M | 32 | 3.2 (2.1,4.3) | 260 | 31.0 (27.2,34.7) |
F | 18 | 1.4 (0.8,2.2) | 86 | 10.4 (8.2,12.6) | |
Non-gonadal | M | 23 | 2.0 (1.3,3.0) | 32 | 3.8 (2.5,5.2) |
F | 42 | 4.1 (2.9,5.4) | 41 | 5.0 (3.5,6.6) | |
Carcinomas | M | 39 | 2.9 (2.0,3.9) | 221 | 26.4 (22.9,29.9) |
F | 54 | 4.5 (3.3,5.7) | 472 | 56.5 (51.4,61.6) | |
Thyroid | M | 9 | 0.7 (0.3,1.3) | 23 | 2.8 (1.7,4.1) |
F | 9 | 0.7 (0.3,1.4) | 61 | 7.4 (5.6,9.3) | |
Melanoma | M | 7 | 0.5 (0.2,1.1) | 61 | 7.4 (5.5,9.2) |
F | 16 | 1.4 (0.8,2.3) | 148 | 17.9 (15.0,20.7) | |
Skin | M | 4 | 0.3 (0.1,0.7) | 39 | 4.6 (3.1,6.0) |
F | 4 | 0.3 (0.1,0.7) | 43 | 5.2 (3.6,6.7) | |
Breast | M | 0 | - | 1 | 0.1 (0.0,0.7) |
F | 0 | - | 42 | 4.9 (3.4,6.4) | |
Genital/other reproductive | M | 0 | - | 0 | - |
F | 1 | 0.1 (0.0,0.6) | 85 | 9.9 (7.8,12.0) | |
Lung and bronchial | M | 1 | 0.1 (0.0,0.4) | 7 | 0.8 (0.3,1.7) |
F | 2 | 0.1 (0.0,0.5) | 5 | 0.6 (0.2,1.4) | |
Colorectal | M | 0 | - | 19 | 2.3 (1.4,3.6) |
F | 2 | 0.1 (0.0,0.5) | 9 | 1.1 (0.5,2.0) | |
TOTAL | M | 886 | 76.8 (71.7,81.9) | 957 | 115.7 (108.3,123.0) |
F | 791 | 73.0 (67.8,78.1) | 942 | 114.3 (107.0,121.6) | |